ARCHIVES

Top Officials Resign From San Antonio’s Institute for Drug Development.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

FDA Recruiting ODAC Consumer Rep Candidates

March 31, 1995

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

October 18, 1996

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992